Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Other | Common Stock | 22.6k | $48.00 | $1.1M | | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Common Stock | 85 | $48.00 | $4.1k | | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Common Stock | 5k | $0.00 | $0 | | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Other | Common Stock | 20k | $48.00 | $960k | See footnote | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Other | Common Stock | 15k | $48.00 | $720k | See footnote | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Common Stock | 30k | $48.00 | $1.4M | See footnote | 07/30/2019 |
07/30/2019 | ARRAY BIOPHARMA INC | ARRY | Disposition | Stock Option (Right to Buy) | 25k | $14.55 | $363.8k | | 07/30/2019 |
02/06/2019 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 25k | $10.47 | $261.8k | | 02/06/2019 |
02/06/2019 | ARRAY BIOPHARMA INC | ARRY | Sale | Common Stock | 5k | $20.85 | $104.3k | See footnote | 02/06/2019 |
02/06/2019 | ARRAY BIOPHARMA INC | ARRY | Sale | Common Stock | 5k | $20.82 | $104.1k | See footnote | 02/06/2019 |
02/06/2019 | ARRAY BIOPHARMA INC | ARRY | Sale | Common Stock | 25k | $20.51 | $512.7k | | 02/06/2019 |
10/26/2018 | ARRAY BIOPHARMA INC | ARRY | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 10/25/2018 |
10/25/2018 | ARRAY BIOPHARMA INC | ARRY | Grant | Stock Option (Right to Buy) | 25k | $14.55 | $363.8k | | 10/25/2018 |
10/25/2018 | ARRAY BIOPHARMA INC | ARRY | Grant | Restricted Stock Units | 5k | $0.00 | $0 | | 10/25/2018 |
07/06/2018 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 25k | $5.95 | $148.8k | | 07/06/2018 |
07/06/2018 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 25k | $5.13 | $128.2k | | 07/06/2018 |
07/06/2018 | ARRAY BIOPHARMA INC | ARRY | Sale | Common Stock | 50k | $17.45 | $872.5k | | 07/06/2018 |
02/09/2018 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 25k | $3.87 | $96.8k | | 02/09/2018 |
02/09/2018 | ARRAY BIOPHARMA INC | ARRY | Sale | Common Stock | 50k | $17.01 | $850.5k | | 02/09/2018 |
02/09/2018 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 25k | $5.60 | $140k | | 02/09/2018 |
10/27/2017 | ARRAY BIOPHARMA INC | ARRY | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 10/26/2017 |
10/27/2017 | ARRAY BIOPHARMA INC | ARRY | Exercise | Common Stock | 5k | $10.47 | $52.4k | | 10/26/2017 |
10/26/2017 | ARRAY BIOPHARMA INC | ARRY | Grant | Stock Option (Right to Buy) | 25k | $10.47 | $261.8k | | 10/26/2017 |
10/26/2017 | ARRAY BIOPHARMA INC | ARRY | Grant | Restricted Stock Units | 5k | $0.00 | $0 | | 10/26/2017 |
06/28/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $12.06 | $144.7k | | 06/28/2017 |
03/10/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 3.3k | $14.31 | $47.2k | See Footnote | 03/09/2017 |
03/09/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 2.5k | $14.38 | $36k | See Footnote | 03/09/2017 |
03/08/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 5k | $14.70 | $73.5k | See Footnote | 03/06/2017 |
03/06/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 608 | $16.24 | $9.9k | See Footnote | 03/06/2017 |
03/06/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 9.4k | $15.71 | $147.6k | See Footnote | 03/06/2017 |
02/28/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 2.3k | $13.54 | $30.6k | See Footnote | 02/24/2017 |
02/27/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 1.5k | $13.79 | $20.7k | See Footnote | 02/24/2017 |
02/24/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 6.5k | $14.04 | $91.3k | See Footnote | 02/24/2017 |
02/23/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 1.8k | $13.65 | $24.6k | See Footnote | 02/22/2017 |
02/22/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 4.1k | $14.36 | $58.9k | See Footnote | 02/22/2017 |
|